Ascendis Pharma A/S ASND
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 137.67 | -0.64 | 383 | -38 | ||
| 2024Q3 | 149.31 | -1.72 | -96,743 | -99 | ||
| 2024Q2 | 136.38 | -1.91 | -133,257 | -109 | ||
| 2024Q1 | 151.17 | -2.30 | -49,145 | -131 | ||
| 2023Q4 | 125.95 | -1.54 | -36,611 | -87 | ||
| 2023Q3 | 93.64 | -2.88 | -134,407 | -162 | ||
| 2023Q2 | 89.25 | -2.16 | -140,838 | -121 | ||
| 2023Q1 | 107.22 | -1.98 | -143,685 | -111 | ||
| 2022Q4 | 122.13 | -3.70 | -147,386 | -207 | ||
| 2022Q3 | 103.26 | -3.03 | -144,505 | -169 | ||
| 2022Q2 | 92.96 | -1.46 | -141,893 | -81 | ||
| 2022Q1 | 117.36 | -2.21 | -128,029 | -125 | ||
| 2021Q4 | 134.53 | -112,581 | -106 | |||
| 2021Q3 | 159.39 | -1.47 | -96,932 | -80 | ||
| 2021Q2 | 131.55 | -2.50 | -117,629 | -134 | ||
| 2021Q1 | 128.88 | -1.17 | -124,650 | -63 | ||
| 2020Q4 | 166.78 | -95,643 | -139 | |||
| 2020Q3 | 154.32 | -2.31 | -78,825 | -122 | ||
| 2020Q2 | 147.90 | -1.97 | -82,947 | -95 |